Next Article in Journal
The Serious Illness Care Program in Oncology: Evidence, Real-World Implementation and Ongoing Barriers
Next Article in Special Issue
Is It Time to Commit to a Process to Re-Evaluate Oncology Drugs? A Descriptive Analysis of Systemic Therapies for Solid Tumour Indications Reviewed in Canada from 2017 to 2021
Previous Article in Journal
Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma
Previous Article in Special Issue
Closing the Gaps to Timely Patient Access: Perspectives on Conditional Funding Models
 
 
Article

Article Versions Notes

Curr. Oncol. 2022, 29(3), 1514-1526; https://doi.org/10.3390/curroncol29030127
Action Date Notes Link
article pdf uploaded. 1 March 2022 15:19 CET Version of Record https://www.mdpi.com/1718-7729/29/3/127/pdf-vor
article pdf uploaded. 1 March 2022 15:46 CET Updated version of record https://www.mdpi.com/1718-7729/29/3/127/pdf-vor
article supplementary file uploaded. 1 March 2022 15:46 CET - https://www.mdpi.com/1718-7729/29/3/127#supplementary
article pdf uploaded. 1 March 2022 15:47 CET Updated version of record https://www.mdpi.com/1718-7729/29/3/127/pdf-vor
article xml file uploaded 3 March 2022 11:44 CET Original file -
article xml uploaded. 3 March 2022 11:44 CET Update https://www.mdpi.com/1718-7729/29/3/127/xml
article pdf uploaded. 3 March 2022 11:44 CET Updated version of record https://www.mdpi.com/1718-7729/29/3/127/pdf
article html file updated 3 March 2022 11:46 CET Original file -
article html file updated 1 August 2022 03:35 CEST Update https://www.mdpi.com/1718-7729/29/3/127/html
Back to TopTop